Axelyf, Inc.
Biotechnology company · Chestnut Hill, Massachusetts, United States
Axelyf, Inc. is a biotechnology company headquartered in Chestnut Hill, Massachusetts, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $4.8 million sold in a notice filed in 2025.
Axelyf at a glance
What does Axelyf do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $4.8 million sold (2025).
Frequently asked questions about Axelyf
Where is Axelyf headquartered?
Axelyf, Inc. is headquartered in Chestnut Hill, Massachusetts, United States.
What does Axelyf do?
Axelyf, Inc. is a biotechnology company.
When was Axelyf founded?
The earliest incorporation on record for Axelyf, Inc. is in 2025, according to public company registers.
Similar companies
- Galibra Neuroscience, Inc.Chestnut Hill, Massachusetts, United States
- PhenoSolve LLCChestnut Hill, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences